Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...

Ultimately, while clinical training teaches nurses how to care for patients within a system, business education empowers them ...

Amazon, Axon Enterprise, Google, Meta and Oracle backed expanding electronic prior authorization to self-funded employer ...

MedCity News has long covered innovation in healthcare. We have also hosted events bringing together investors, startups and the healthcare ecosystem in a bid to connect those novel companies to ...

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out ...

GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to ...

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...

Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform ...

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or ...